Literature DB >> 20946286

Clinical predictors of conduction disease progression in type I myotonic muscular dystrophy.

Saman Nazarian1, Kathryn R Wagner, Brian S Caffo, Gordon F Tomaselli.   

Abstract

BACKGROUND: Patients with type I myotonic muscular dystrophy (DM1) are at risk for sudden death due to atrioventricular conduction block. We sought to characterize the trends and predictors of time-dependent electrocardiographic (ECG) variations in patients with DM1.
METHODS: Seventy patients with DM1 underwent standard electrocardiography at first evaluation and routine and symptom prompted follow-up. Individual variations in ECG conduction intervals were assessed using spaghetti plots. Clinical predictors of conduction disease progression were assessed using multivariate random effects regression models of panel data clustered by patient and adjusted for heart rate.
RESULTS: Substantial individual variability was noted in time-dependent changes in PR, QRS, and QTc intervals of patients with DM1. Changes in the QTc interval were closely associated with prolongation of the QRS interval. Age, the presence of paroxysmal atrial flutter or fibrillation, and the number of cytosine-thymine-guanine (CTG) repeats were independent positive predictors of time-dependent PR and QRS prolongation during long-term follow-up. Female sex was negatively associated with PR prolongation but positively associated with QTc prolongation. Lower left ventricular ejection fraction was associated with greater QRS interval progression during long-term follow-up but was not predictive of PR interval progression.
CONCLUSIONS: Patients with DM1 can develop rapid changes in cardiac conduction intervals. Paroxysmal atrial flutter or fibrillation, older age, and larger CTG expansions predict greater time-dependent PR and QRS interval prolongation and warrant particular attention in the arrhythmic evaluation of this high risk patient subset. ©2010, The Authors. Journal compilation ©2010 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2010        PMID: 20946286      PMCID: PMC3035751          DOI: 10.1111/j.1540-8159.2010.02905.x

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  11 in total

Review 1.  Electrocardiographic abnormalities in patients with myotonic dystrophy.

Authors:  R C Florek; D W Triffon; D E Mann; S P Ringel; M J Reiter
Journal:  West J Med       Date:  1990-07

2.  Does cytosine-thymine-guanine (CTG) expansion size predict cardiac events and electrocardiographic progression in myotonic dystrophy?

Authors:  N R Clarke; A D Kelion; J Nixon; D Hilton-Jones; J C Forfar
Journal:  Heart       Date:  2001-10       Impact factor: 5.994

3.  Cardiac involvement in myotonic dystrophy.

Authors:  P V Fragola; M Luzi; L Calò; G Antonini; M Borzi; D Frongillo; D Cannata
Journal:  Am J Cardiol       Date:  1994-11-15       Impact factor: 2.778

4.  Long-term follow-up of arrhythmias in patients with myotonic dystrophy treated by pacing: a multicenter diagnostic pacemaker study.

Authors:  Arnaud Lazarus; Jean Varin; Dominique Babuty; Frédéric Anselme; Joel Coste; Denis Duboc
Journal:  J Am Coll Cardiol       Date:  2002-11-06       Impact factor: 24.094

5.  Value of the electrocardiogram in determining cardiac events and mortality in myotonic dystrophy.

Authors:  J A Colleran; R J Hawley; E E Pinnow; P F Kokkinos; R D Fletcher
Journal:  Am J Cardiol       Date:  1997-12-01       Impact factor: 2.778

6.  Cardiac involvement in myotonic muscular dystrophy.

Authors:  J R Moorman; R E Coleman; D L Packer; J A Kisslo; J Bell; B D Hettleman; J Stajich; A D Roses
Journal:  Medicine (Baltimore)       Date:  1985-11       Impact factor: 1.889

7.  Electrocardiographic abnormalities and sudden death in myotonic dystrophy type 1.

Authors:  William J Groh; Miriam R Groh; Chandan Saha; John C Kincaid; Zachary Simmons; Emma Ciafaloni; Rahman Pourmand; Richard F Otten; Deepak Bhakta; Girish V Nair; Mohammad M Marashdeh; Douglas P Zipes; Robert M Pascuzzi
Journal:  N Engl J Med       Date:  2008-06-19       Impact factor: 91.245

8.  Usefulness of clinical and electrocardiographic data for predicting adverse cardiac events in patients with myotonic dystrophy.

Authors:  Robert Breton; Jean Mathieu
Journal:  Can J Cardiol       Date:  2009-02       Impact factor: 5.223

9.  Cardiac involvement in a large kindred with myotonic dystrophy. Quantitative assessment and relation to size of CTG repeat expansion.

Authors:  L S Tokgozoglu; T Ashizawa; A Pacifico; R M Armstrong; H F Epstein; W A Zoghbi
Journal:  JAMA       Date:  1995-09-13       Impact factor: 56.272

10.  Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3' end of a transcript encoding a protein kinase family member.

Authors:  J D Brook; M E McCurrach; H G Harley; A J Buckler; D Church; H Aburatani; K Hunter; V P Stanton; J P Thirion; T Hudson
Journal:  Cell       Date:  1992-02-21       Impact factor: 41.582

View more
  3 in total

1.  A 34-year longitudinal study on long-term cardiac outcomes in DM1 patients with normal ECG at baseline at an Italian clinical centre.

Authors:  Elisabetta Bucci; Marco Testa; Loretta Licchelli; Alessandra Frattari; Nadia Attalla El Halabieh; Erica Gabriele; Giulia Pignatelli; Tiziana De Santis; Laura Fionda; Fiammetta Vanoli; Stefania Morino; Matteo Garibaldi; Antonella Di Pasquale; Nicola Vanacore; Annalisa Botta; Giovanni Antonini
Journal:  J Neurol       Date:  2018-02-10       Impact factor: 4.849

2.  Biophysical mechanisms for QRS- and QTc-interval prolongation in mice with cardiac expression of expanded CUG-repeat RNA.

Authors:  Kevin M Tylock; David S Auerbach; Zhen Zhi Tang; Charles A Thornton; Robert T Dirksen
Journal:  J Gen Physiol       Date:  2020-02-03       Impact factor: 4.086

3.  Clinical utility of 12-lead electrocardiogram in evaluating heart disease in patients with muscular dystrophy: Assessment of left ventricular hypertrophy, conduction disease, and cardiomyopathy.

Authors:  Anish Nikhanj; Haran Yogasundaram; Shane Kimber; Zaeem A Siddiqi; Gavin Y Oudit
Journal:  Ann Noninvasive Electrocardiol       Date:  2021-07-11       Impact factor: 1.468

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.